National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 54226 [2022-19051]
Download as PDF
<![CDATA[
54226
Federal Register / Vol. 87, No. 170 / Friday, September 2, 2022 / Notices
Dated: August 30, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19049 Filed 9–1–22; 8:45 am]
BILLING CODE 4140–01–P
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award
supplemental funding.
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
lotter on DSK11XQN23PROD with NOTICES1
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group Microbiology and Infectious Diseases
Research Study Section Microbiology and
Infectious Diseases Research Study Section.
Date: October 18–19, 2022.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G62,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3G62, Rockville, MD 20892, (240) 669–5081,
ecohen@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 30, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:40 Sep 01, 2022
Jkt 256001
Substance Abuse and Mental Health
Services Administration Fiscal Year
(FY) 2022 Notice of Supplemental
Funding Opportunity
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2022–19051 Filed 9–1–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
This is a notice of intent to
award supplemental funding to the
Suicide Prevention Resource Center
(SPRC) recipient funded in FY 2020
under Notice of Funding Opportunity
(NOFO) SM–20–11. This is to inform
the public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting an
administrative supplement, which is
consistent with the scope of the initial
award, of up to $1,609,838, for one-year
to the SPRC recipient, University of
Oklahoma Health Sciences Center. This
recipient was funded in FY 2020 under
the SPRC Notice of Funding
Opportunity (NOFO) SM–20–011 with a
project end date of November 30, 2025.
This supplement will provide continued
support for the HHS Behavioral Health
Coordinating Committee’s,
Comprehensive Community Suicide
Prevention Workgroup in the
development of recommendations to
increase the community-based suicide
prevention infrastructure; provide staff
support and technical assistance on a
new platform that will be used to train
the suicide prevention workforce on
approaches to address the needs of
individuals at risk for suicide; provide
additional suicide prevention technical
assistance for states, tribes, territories,
and community-based organizations in
the implementation of suicide
prevention; and conduct an evaluation,
in coordination with the National
Action Alliance for Suicide Prevention,
of 988 call centers to ensure 988
implementation, programmatic and
messaging efforts are well informed by
the unique needs of populations at high
risk or disproportionately impacted by
suicide-related behaviors.
This is not a formal request for
application. Assistance will only be
provided to the SPRC Grant recipient,
University of Oklahoma Health Sciences
Center, based on the receipt of a
satisfactory application and associated
budget.
Funding Opportunity Title: Suicide
Prevention Resource Center (SPRC)
NOFO SM–20–011.
Assistance Listing Number: 93.243.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Authority: The SPRC grant is
authorized under Section 520A and
520C of the Public Health Service Act,
as amended.
Justification: Eligibility for this
supplemental funding is limited to the
University of Oklahoma Health Sciences
Center which was funded in FY 2020
under the SPRC NOFO SM–20–011. The
University of Oklahoma Health Sciences
Center since they are currently
providing technical assistance on
suicide prevention and have specialized
expertise conducting needs assessments
to understand the attitudes, knowledge,
and beliefs regarding suicide of various
groups and populations.
Contact: Brandon J. Johnson,
Substance Abuse and Mental Health
Services Administration, 5600 Fishers
Lane, Rockville, MD 20857, telephone
(240) 276–1222; email:
brandon.johnson1@samhsa.hhs.gov.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022–18975 Filed 9–1–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2022 Notice of
Supplemental Funding Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
This is a notice of intent to
award supplemental funding to the
National Center of Excellence for Infant
and Early Childhood Mental Health
Consultation (COE–IECMH) recipient
funded in FY 2019 under Notice of
Funding Opportunity (NOFO) SM–19–
010. This is to inform the public that the
Substance Abuse and Mental Health
Services Administration (SAMHSA) is
supporting an administrative
supplement, which is consistent of the
initial award, up to $900,000 (for oneyear to Georgetown University). This
supplement will provide continued
support for the IECMH grantees in their
efforts to strengthen their IECMH
systems; working with state-level
systems and leaders to integrate grantee
innovations into ongoing initiatives,
policies, and sustainable funding
streams, and/or participate in the
development of new IECMH efforts;
share best practices and advances in
infant and early childhood mental
health with the early childhood field
SUMMARY:
E:\FR\FM\02SEN1.SGM
02SEN1
]]>Agencies
[Federal Register Volume 87, Number 170 (Friday, September 2, 2022)]
[Notices]
[Page 54226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19051]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group Microbiology and Infectious Diseases Research
Study Section Microbiology and Infectious Diseases Research Study
Section.
Date: October 18-19, 2022.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G62,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G62, Rockville, MD
20892, (240) 669-5081, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 30, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19051 Filed 9-1-22; 8:45 am]
BILLING CODE 4140-01-P
